CSI Market
Sign In | Register

Jazz Pharmaceuticals Plc (JAZZ) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access JAZZ quarterly Cash Flow →
Quarterly cash flow trends provide additional context on Jazz Pharmaceuticals Plc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-356.15
Depreciation & amortization41.64
Amortization of Other Assets654.66
Increase (Decrease) in Deferred Revenue0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-86.04
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Other Assets0.00
Share-based Compensation291.13
Proceeds from Equity Method Investment, Dividends or Distributions0.00
Gains (Losses) on Extinguishment of Debt0.00
Increase Decrease In Deferred Rent-
Fair Value Inventory Step Up Adjustment-
Provision For Losses On Accounts Receivable And Inventory19.11
Research And Development Asset Acquired Other Than Through Business Combination Written Off947.86
Increase Decrease In Operating Lease Assets-
Inventory Step Up Value Adjustment147.95
Increase Decrease In Contract With Customer Liability-
Noncash Interest Expense-
Income taxes-407.75
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-106.28
Increase (Decrease) in Accounts Payable39.85
Increase (Decrease) in Accrued Liabilities77.10
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets29.03
Other Working Capital28.02
Other Noncash Income (Expense)3.10
Other net0.00
Payments for (Proceeds from) Other Operating Activities32.54
Discontinued operations0.00
Net Cash flow from Operating Activities1,355.77
Investing Activities
Capital Expenditures-167.25
Sale of Capital Items28.17
Short-term Investments Proceeds0.00
Payments to Acquire Available-for-sale Securities0.00
Real Estate Investments0.00
Payments To Acquire Product Rights-
Paymentsto Acquire In Process Research and Development Other Than Through Business Combination-42.50
Payment To Acquire Assets Net Of Cash Acquired-
Payments To Acquire In Process Research And Development Other Than Through Business Combination-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments-470.28
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Assets, Investing Activities-858.05
Payments to Acquire Additional Interest in Subsidiaries0.00
Proceeds from Divestiture of Businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-1,509.91
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-781.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-17.16
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-75.22
Proceeds From Employee Stock Purchases And Exercise Of Stock Options And Warrants-
Proceeds From Stock Options And Warrants Exercises-
Proceeds From Issuance Of Term Loan-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-873.38
Effect of exchange rate on cash flow6.56
Discontinued operations0.00
Free Cash Flow1,216.69
Total Cash Flow-1,020.97
4 historic quarters locked

Sign in to unlock the full Jazz Pharmaceuticals Plc cash flow history.

Sign In Create Free Account

About Jazz Pharmaceuticals Plc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 24, 2026
  • Source: jazz-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001232524-26-000013

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License